Gilead Sciences as of March 31, 2026
Portfolio Holdings for Gilead Sciences
Gilead Sciences holds 6 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Arcellx (ACLX) | 36.4 | $772M | 6.7M | 114.82 | |
| Arcus Biosciences Incorporated (RCUS) | 32.1 | $679M | 31M | 21.60 | |
| Galapagos NV Spon Adr (GLPG) | 23.7 | $501M | 17M | 30.00 | |
| Assembly Biosciences Com New (ASMB) | 5.9 | $125M | 4.5M | 27.75 | |
| Kyverna Therapeutics (KYTX) | 1.7 | $36M | 4.1M | 8.63 | |
| Xilio Therapeutics (XLO) | 0.3 | $5.5M | 650k | 8.41 |
